NLN: A Comprehensive Resource for Drug Targets and Biomarkers

Target Name: NLN

NCBI ID: G57486

Content of Review Report on NLN Target / Biomarker

NLN

NLN: A Comprehensive Resource for Drug Targets and Biomarkers

National Library of Medicine (NLN) is a comprehensive online database of biomedical and life science literature. It is a valuable resource for researchers, clinicians, and the general public alike, as it provides access to a wide range of biomedical and life science information. One of the key features of NLN is its MeSH (Medical Subject Headings) system, which allows users to search for articles using specific keywords and MeSH terms. This feature is a powerful tool for researchers and clinicians looking for specific information, and it is often used in the search for potential drug targets or biomarkers.

A drug target is a molecule that is designed to interact with a specific protein or enzyme in the body, in order to cause a desired response. These targets are often derived from diseases or disorders, and they can be used to develop new treatments or to improve existing ones. The identification of a potential drug target is an important step in the development of new pharmaceuticals, as it allows researchers to design and test new treatments that target specific proteins or enzymes.

A biomarker is a molecule that is used to monitor or diagnose a specific disease or condition. These molecules can be used to track the progress of a disease, to identify potential drug targets, or to track the effectiveness of a treatment. Biomarkers are often derived from proteins, but they can also be derived from other molecules, such as RNA or DNA.

The identification of potential drug targets or biomarkers is often based on the information contained in NLN. NLN contains a wide range of biomedical and life science literature, including articles on diseases and disorders, as well as on the use of drugs and other therapeutic compounds. By using the MeSH system to search for specific keywords and MeSH terms, researchers and clinicians can quickly and easily identify relevant articles and other resources.

One of the key benefits of using NLN for this purpose is the depth and breadth of the information it provides. NLN contains articles on a wide range of topics, including but not limited to:

* Biochemistry and molecular biology
* Genetics and genomics
* Neuroscience
*Cancer
* Cardiovascular diseases
* Respiratory diseases
*Dermatology
*Infectious diseases
*Public health and preventive medicine

This makes it possible for researchers and clinicians to quickly and easily identify relevant articles and other resources that are specific to their interests. It also allows them to quickly and easily track the progress of a disease or to identify potential drug targets or biomarkers.

Another important feature of NLN is its integration with other resources, such as the National Library of Congress and the National Medical Library Association. This allows users to access not only the text of articles and other resources, but also the metadata associated with those resources, such as the authors, publishers, and publication dates. This metadata can be useful for researchers and clinicians to quickly and easily identify the key players in a field, as well as to track the trends and developments in the field over time.

In addition to its MeSH system, NLN also contains a range of other tools and resources that can be useful for researchers and clinicians looking for potential drug targets or biomarkers. These include:

* The NLN Drug Targets database, which provides information on potential drug targets and the results of drug-related studies.
* The NLN Biomarkers database, which provides information on potential biomarkers and the results of biomarker-related studies.
* The NLN Yaochang (Life Science Library) collection, which includes resources for the life science literature, including articles on genetics, genomics, and biochemistry.

Overall, NLN is a valuable resource for researchers, clinicians, and the general public looking for information on potential drug targets or biomarkers. Its MeSH system and

Protein Name: Neurolysin

Functions: Hydrolyzes oligopeptides such as neurotensin, bradykinin and dynorphin A (By similarity). Acts as a regulator of cannabinoid signaling pathway by mediating degradation of hemopressin, an antagonist peptide of the cannabinoid receptor CNR1 (By similarity)

The "NLN Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NLN comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets